Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1317-1339
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1317
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1317
Figure 4 Heying wuzi formulation improved intracellular oxidative stress.
A and D: A transwell was performed to detect the invasion ability of Human retinal capillary endothelial cell (HRCEC; scar bar: 100 μm); B and E: A tube formation assay was performed to detect the tube-forming ability of HRCEC cells (scar bar: 100 μm); C and F: Cell apoptosis was detected by flow cytometry. Compared with the high glucose (hg) group, aP value < 0.05, bP value < 0.01; compared with the hg + 10% HYWZF serum group, cP value < 0.05, dP value < 0.01. HYWZF: Heying wuzi formulation; NEG: Negative serum; hg: High glucose; ps: 10% HYWZF serum; Con: Control.
- Citation: Wu JJ, Zhang SY, Mu L, Dong ZG, Zhang YJ. Heyingwuzi formulation alleviates diabetic retinopathy by promoting mitophagy via the HIF-1α/BNIP3/NIX axis. World J Diabetes 2024; 15(6): 1317-1339
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1317.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1317